World Health Energy Holdings Files Q2 2024 10-Q

TL;DR

WHEH filed its Q2 10-Q. Software company, formerly pharma. Check financials.

AI Summary

World Health Energy Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Advanced Plant Pharmaceuticals Inc., is based in Boca Raton, Florida, and operates in the pre-packaged software industry. The filing covers financial information for the second quarter of 2024.

Why It Matters

This filing provides investors with an update on the financial performance and position of World Health Energy Holdings, Inc. for the second quarter of 2024.

Risk Assessment

Risk Level: low — This is a routine quarterly filing and does not appear to contain any immediately alarming information.

Key Numbers

• Q2 2024 — Reporting Period (Financial results for the second quarter of 2024 are detailed.)
• 1231 — Fiscal Year End (The company's fiscal year concludes on December 31st.)

Key Players & Entities

• WORLD HEALTH ENERGY HOLDINGS, INC. (company) — Filer
• ADVANCED PLANT PHARMACEUTICALS INC (company) — Former Company Name
• BOCA RATON (location) — Business Address City
• 20240630 (date) — Period of Report
• 20240819 (date) — Filing Date

FAQ

Filing Documents

• form10-q.htm (10-Q) — 995KB
• ex10-3.htm (EX-10.3) — 101KB
• ex10-4.htm (EX-10.4) — 167KB
• ex10-5.htm (EX-10.5) — 9KB
• ex31-1.htm (EX-31.1) — 12KB
• ex32-1.htm (EX-32.1) — 7KB
• 0001493152-24-033070.txt ( ) — 3891KB
• when-20240630_cal.xml (EX-101.CAL) — 41KB
• when-20240630_def.xml (EX-101.DEF) — 85KB
• when-20240630_lab.xml (EX-101.LAB) — 252KB
• when-20240630_pre.xml (EX-101.PRE) — 185KB
• when-20240630.xsd (EX-101.SCH) — 18KB
• form10-q_htm.xml (XML) — 389KB

– Financial Statements – Unaudited

Item 1 – Financial Statements – Unaudited 4 Condensed Consolidated Balance Sheets – June 30, 2024 and December 31, 2023 5 Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 6 Condensed Consolidated Statement of Changes in Stockholders' Deficit for the three and six months ended June 30, 2024 and 2023 7 Condensed Consolidated Statements of Cash Flows for the three months ended June 30, 2024 and 2023 9 Notes to Condensed Consolidated Financial Statements 10

– Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations 15

– Quantitative and Qualitative Disclosures About Market Risk

Item 3 – Quantitative and Qualitative Disclosures About Market Risk 26

– Controls and Procedures

Item 4 – Controls and Procedures 26

– Legal Proceedings

Item 1 – Legal Proceedings 27

– Risk Factors

Item 1A – Risk Factors 27

– Unregistered Sales of Equity Securities and Use of Proceeds

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds 27

– Defaults upon Senior Securities

Item 3 – Defaults upon Senior Securities 28

– Mine Safety Disclosures

Item 4 – Mine Safety Disclosures 28

– Other Information

Item 5 – Other Information 28

– Exhibits

Item 6 – Exhibits 28 Exhibit Index 28

SIGNATURES

SIGNATURES 29 2 WORLD HEALTH ENERGY HOLDINGS, INC. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2024 (UNAUDITED) 3 WORLD HEALTH ENERGY HOLDINGS, INC. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2024 IN U.S. DOLLARS (UNAUDITED) TABLE OF CONTENTS Page CONDENSED CONSOLIDATED FINANCIAL STATEMENTS: Interim Condensed Consolidated Balance sheets 5 Interim Condensed Consolidated Statements of Comprehensive loss 6 Interim Condensed Consolidated Statements of stockholders' equity 7 Interim Condensed Consolidated Statements of cash flows 9 Notes to Interim condensed consolidated financial statements 10 - 14 4 WORLD HEALTH ENERGY HOLDINGS, INC. CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS (U.S. dollars except share and per share data) June 30, December 31, 2024 2023 Assets Current Assets Cash and cash equivalents 125,807 46,435 Accounts receivable, net of allowance for credit losses of $ 2,842 and $ 7,545 as of June 30, 2024 and December 31, 2023. respectively 23,470 51,011 Inventory 26,794 4,699 Other current assets 207,495 148,749 Total Current assets 383,566 250,894 Non-current assets Right-of-use asset 149,075 116,548 Long term prepaid expenses 24,600 25,496 Property and equipment, net 49,004 55,473 Funds in respect of employee rights upon termination 60,666 56,558 Intangible assets 9,693,958 9,693,958 Total non-current assets 9,977,303 9,948,033 Total assets 10,360,869 10,198,927 Liabilities and Stockholders' Deficit Current Liabilities Short term credit from related party 133,395 - Accounts payable 79,799 106,964 Short term operating lease liability 86,818 56,245 Other current liabilities 490,381 554,928 Total Current Liabilities 790,393 718,137 Non-current Liabilities Liability for employee rights upon retirement 239,874 217,617 Long term loan from parent company 2,012,339 2,012,339 Long term op

financial statements

financial statements. NOTE 3 – COMMON STOCK During the six months ended June 30, 2024, the Company received subscription proceeds of $ 770,173 under the November 1, 2022, investment agreement with Mr. Baumeohll in respect o

View Full Filing

View this 10-Q filing on SEC EDGAR